Вы искали: brejost (Словенский - Английский)

brejost
pregnancy:

brejost/laktacija
pregnancy / lactation

brejost in laktacija
pregnancy and lactation

brejost in plodnost:
pregnancy and fertility:

brejost, laktacija, plodnost:
pregnancy, lactation, fertility:

brejost, laktacija in plodnost:
pregnancy, lactation and fertility:

glejte poglavje "brejost ali laktacija".
see section “pregnancy or lactation”.

glejte tudi poglavje "brejost in laktacija".
see also section "pregnancy and lactation".

brejost: lahko se uporablja v obdobju brejosti.
pregnancy: can be used during pregnancy.

glejte poglavje 4. 7 (brejost in laktacija).
see section 4.7 (pregnancy and lactation).

proizvodna stopnja: prasitev; parjenje, brejost (drugo?);
production stage: maternity; mating, gestation (other?);

zadeva brejost, razvoj zarodka in ploda, skotitev ali postnatalni razvoj.
in studies performed in rats and rabbits no clinically relevant evidence of harmful effects with respect to pregnancy, embryonal/ foetal development, parturition or postnatal development was observed.

injekcije zdravila startvac niso imele škodljivih učinkov na brejost, porod ali teleta krav.
startvac injections did not have any harmful effects on pregnancy or giving birth, or on the cows’ calves.

ostale samice sesalcev: od zadnjega dela brej osti, dokler ni potrjena naslednja brejost.
other female mammals: from the last part of gestation until the next gestation is confirmed.

po cepljenju v različnih obdobjih brejosti niso opazili nobenih negativnih učinkov na brejost, žrebitev in mladiče.
no negative influence on gestation, foaling and offspring of mares was observed after vaccination at different times during pregnancy.

ne uporabite pri kobilah v obdobju brejosti in laktacije (glejte poglavje brejost in laktacija).
do not use in pregnant or lactating mares (see section “pregnancy and lactation”).

to lahko povzroči transplacentalen prenos virusa cepiva, vendar v študijah niso opazili nikakršnih neželenih učinkov na plod ali brejost.
this may result in transplacental transmission on the vaccine virus, but no adverse effects on foetus or pregnancy was observed in studies.

vsako parjenje, do katerega pride več kot 12 mesecev po uporabi zdravila za uporabo v veterinarski medicini, lahko povzroči brejost.
any mating that occurs more than 12 months after the administration of the veterinary medicinal product may result in pregnancy.

enkratni subkutani odmerek 2,2 g/kg v četrtem dnevu brejosti je prekinil brejost pri 100 % testiranih samic hrčkov.
a single s.c. dose of 2.2 g/kg administered on gestation day 4 terminated pregnancy in 100% of tested hamster.

v študijah na podganah in kuncih niso opazili klinično pomembnih znakov škodljivih učinkov, kar zadeva brejost, razvoj zarodka in ploda, skotitev ali postnatalni razvoj.
in studies performed in rats and rabbits no clinically relevant evidence of harmful effects with respect to pregnancy, embryonal/ foetal development, parturition or postnatal development was observed.